Enzyme Characterization Services
Enzymatic Property Analysis for Enzymes That Must Perform
Measure activity, kinetics, specificity, and inhibition under defined assay conditions to guide enzyme selection, optimization, and release testing.
What Enzymatic Property Analysis Delivers
Enzymatic property analysis measures how an enzyme actually behaves in solution: how fast it converts substrate, how tightly it binds that substrate, which substrates it prefers, and how inhibitors or matrix components change its rate. Rather than a single endpoint number, the service builds a defined biochemical profile under controlled assay conditions so that enzyme selection, formulation, and process decisions rest on measured catalytic behavior.
This work supports natural and engineered enzymes, enzyme-based drugs, enzyme inhibitors, and enzymatic biomarkers. Typical questions include whether a candidate enzyme is active enough for an intended application, how its kinetics shift with buffer, pH, or temperature, and whether an inhibitor shows the potency and selectivity needed to advance. Each program is scoped around the decision the data must support, so the assay panel, detection chemistry, and reporting depth are defined case by case.
Catalytic Activity Quantification
Activity is quantified by substrate conversion or product formation over time, using chromogenic, fluorogenic, or coupled detection systems selected for the enzyme and matrix.
- Substrate selection and assay buffer optimization
- Rate measurement under defined temperature and pH
- Detection format matched to enzyme class and sample
Kinetic Parameter Determination
Kinetic constants describe how an enzyme responds to substrate concentration, giving a quantitative basis for comparing variants, lots, or process conditions.
- Km and Vmax determination
- kcat and specificity constant reporting
- Substrate-range design scoped per project
Inhibitor Potency and Selectivity
Dose-response profiling establishes inhibitor potency and selectivity, supporting mechanism studies and candidate ranking for inhibitor programs.
- Dose-response curve generation
- IC50 and ki determination
- Specificity profiling against related targets
Assay Parameters and Project Scope
Every enzymatic property program is defined by the enzyme, the substrate, the detection chemistry, and the regulatory context. The table below shows the parameters that are commonly customized after consultation; the final panel, replicate structure, and reporting format are fixed in the project scope.
Because enzymes differ widely in stability, cofactor requirements, and matrix tolerance, assay conditions are optimized per target rather than applied from a fixed template. Where a program supports regulated work, assay execution and documentation can be aligned to GLP or GMP expectations as scoped.
| Parameter | Typical project scope | Detection / readout | Reporting |
|---|---|---|---|
| Enzyme activity | Natural or engineered enzymes; activity confirmed under defined conditions | Chromogenic, fluorogenic, or coupled assay | Specific activity and rate data |
| Kinetic constants | Km, Vmax, kcat, and specificity constant as scoped | Substrate titration series | Fitted kinetic parameters with curve data |
| Inhibitor profiling | Dose-response and selectivity panels as scoped | Inhibitor titration with activity readout | IC50 / ki values and curve fits |
| Biomarker activity | Enzyme activity measured in biological matrices | Matrix-compatible detection format | Matrix-specific activity results |
| QC / CMC release testing | Release and stability testing for enzyme-based drugs as scoped | Validated activity assay format | Release-style data package |
| Regulatory alignment | GLP- or GMP-aligned execution when required by the program | Controlled assay conditions and records | Documentation aligned to program needs |
How an Engagement Works
The workflow below describes the sequence of scientific and documentation steps in a typical enzymatic property analysis program. Timelines are agreed in the project scope and depend on assay complexity, sample availability, and regulatory requirements.
Scope and assay design
We review the enzyme, intended application, and decision the data must support, then define the assay panel, substrate, detection chemistry, and controls.
Substrate and buffer optimization
Assay buffer, pH, temperature, cofactors, and substrate concentration are optimized so that measured rates fall within a reliable detection window.
Activity and kinetics measurement
Activity is quantified by substrate conversion or product formation over time, and kinetic constants such as Km, Vmax, and kcat are determined from substrate titration data.
Inhibition and specificity profiling
Where required, inhibitor dose-response curves are generated to establish potency and selectivity, with IC50 or ki values reported alongside the activity data.
Why Programs Choose This Service
Enzymatic property data is only useful if it reflects the conditions the enzyme will actually meet. Our approach keeps assay design tied to the application, whether that is a food or dairy process, an industrial biocatalysis step, or a regulated enzyme-based drug program.
Programs are supported by defined assay conditions, documented methods, and reporting that can be reviewed alongside other characterization data.
Assays Built Around the Decision
Assay conditions are chosen to reflect the pH, temperature, substrate, and matrix the enzyme will encounter in its intended use.
- Conditions matched to process or product context
- Controls and blanks defined in the scope
- Interpretation notes tied to the application
GLP- and GMP-Aligned Execution
For programs that require it, assay execution and documentation can be aligned to GLP or GMP expectations, supporting preclinical and CMC packages.
- Controlled assay conditions and records
- QC and CMC release testing as scoped
- Documentation aligned to program needs
From Activity to Biomarkers
The same framework supports enzyme activity assays, inhibitor profiling, and biomarker enzyme activity measurement in biological matrices.
- Natural and engineered enzymes
- Enzyme inhibitors and enzyme-based drugs
- Biomarker activity in biological matrices
Detection Formats and Readouts
Detection chemistry is selected to match the enzyme, substrate, and matrix. Chromogenic and fluorogenic substrates give direct readouts for many hydrolases and proteases, while coupled assays extend detection to reactions that do not produce a convenient signal on their own.
The table summarizes common format choices and the readouts they support. Final selection is confirmed during assay design.
| Format | Readout | Notes | |
|---|---|---|---|
| Chromogenic substrate | Hydrolases and proteases with suitable chromogenic substrates | Absorbance change over time | Simple, direct rate measurement |
| Fluorogenic substrate | Enzymes where higher sensitivity is useful | Fluorescence increase over time | Suited to lower activity samples |
| Coupled assay | Reactions without a convenient direct signal | Signal from coupled reporter reaction | Requires control of coupling enzymes |
| Inhibitor titration | Inhibitor potency and selectivity programs | Activity versus inhibitor concentration | Supports IC50 and ki determination |
Applications Across Enzyme Programs
Enzymatic property analysis is used wherever an enzyme's catalytic behavior determines whether a candidate, lot, or process is fit for purpose. The examples below reflect common program types; each is scoped around the specific enzyme and decision.
For food and dairy applications, activity and specificity data help confirm that an enzyme performs under process conditions. For therapeutic and diagnostic programs, the same measurements feed into candidate selection, comparability, and release testing.
Process Enzyme Evaluation
Activity, stability, and specificity data support enzyme selection and optimization for food and dairy processes, including recombinant enzymes such as chymosins.
- Activity under process-relevant conditions
- Specificity and side-activity assessment
- Comparability between lots or variants
Enzyme Drug and Inhibitor Programs
Potency, kinetics, and inhibition data support preclinical characterization and CMC activities for enzyme-based drugs and enzyme inhibitors.
- Potency and mechanism characterization
- QC and CMC release testing as scoped
- Data packages aligned to program stage
Enzyme Activity in Biological Matrices
Enzyme activity can be measured in biological matrices to support biomarker studies where catalytic activity, rather than mass, is the relevant readout.
- Matrix-compatible assay formats
- Activity-based biomarker measurement
- Results reported with matrix context
Sample and Information Requirements
Clear inputs make assay design faster and more reliable. The table lists the information and materials typically requested at project start; exact requirements are confirmed once the assay panel is agreed.
Where sample amounts are limited, assay formats and replicate structures can be adjusted during scoping to make the best use of available material.
| Item | What to provide | Purpose | Notes |
|---|---|---|---|
| Enzyme sample | Purified enzyme or enzyme-containing sample | Activity and kinetics measurement | Amount and format confirmed in scoping |
| Substrate | Preferred substrate or substrate class | Assay design and specificity testing | Alternatives discussed if needed |
| Matrix information | Buffer, matrix, or formulation context | Assay condition selection | Supports matrix-compatible formats |
| Inhibitor compounds | Inhibitors or reference compounds for profiling | Dose-response and selectivity testing | When inhibition work is in scope |
| Regulatory context | Intended use and required documentation | GLP or GMP alignment planning | Defined during project scoping |
| Reference data | Prior results or specification limits | Comparability and acceptance criteria | Used to frame reporting |
Quality, Documentation, and Support
Assay results are only as strong as the records behind them. Programs are supported with documented assay conditions, control data, and reporting that can be reviewed alongside other characterization or release documentation.
For regulated programs, execution and documentation can be aligned to GLP or GMP expectations as defined in the project scope.
Structured Reporting
Reports include assay conditions, control performance, raw and fitted data, and interpretation notes so results can be reviewed and reused.
- Assay conditions and controls recorded
- Raw and fitted data included
- Interpretation notes tied to scope
GLP / GMP Alignment
Where a program requires regulated execution, assay conditions and documentation can be aligned to GLP or GMP expectations.
- Controlled assay conditions
- Records aligned to program needs
- QC and CMC testing as scoped
Scientific Contact Throughout
A named scientific contact is assigned at project start, with milestone review calls and email response within one business day.
- Named scientific contact at project start
- Milestone review calls
- Email response within one business day
Planning Your Enzymatic Property Program
The most useful starting point is a short description of the enzyme, its intended application, and the decision the data must support. From there, the assay panel, detection format, and reporting depth can be defined together.
Programs can range from a focused activity measurement to a broader kinetics and inhibition package, depending on the stage and the questions that need answering.
FAQ
What is the difference between enzymatic property analysis and a simple activity measurement?
A simple activity measurement reports whether the enzyme converts substrate under one set of conditions. Enzymatic property analysis goes further by determining kinetic constants such as Km, Vmax, and kcat, and, where relevant, inhibitor potency and selectivity, so the enzyme's behavior can be compared across variants, lots, or process conditions.
Which enzymes and sample types can be analyzed?
The service supports natural and engineered enzymes, enzyme-based drugs, enzyme inhibitors, and enzymatic biomarkers. Samples can range from purified enzyme preparations to enzyme-containing biological matrices, with the assay format selected to suit the sample and the readout required.
How are assay conditions chosen for my enzyme?
Assay buffer, pH, temperature, cofactors, and substrate concentration are optimized during assay design so that measured rates fall within a reliable detection window. Conditions are chosen to reflect the environment the enzyme will encounter in its intended application, and the final set is documented in the report.
Can the work be aligned to GLP or GMP requirements?
For programs that require regulated execution, assay conditions and documentation can be aligned to GLP or GMP expectations as defined in the project scope. This supports preclinical characterization and CMC activities, including QC and release testing for enzyme-based drugs where applicable.
What do I receive at the end of a program?
You receive a structured report containing the assay conditions used, control performance, raw and fitted data, and interpretation notes. Kinetic parameters, inhibitor values, or matrix-specific activity results are reported as agreed in the scope, so the data can be reviewed alongside other characterization or release documentation.
References
Define the assay panel for your enzyme
Share the enzyme, its intended application, and the decision the data must support. We will propose an assay design covering activity, kinetics, and inhibition as needed, with scope confirmed before work begins.